Medical Injection Needle Market Forecast, Trend Analysis & Competition Tracking - Global Industry Insights 2015 to 2031

Syringes and needles are important medical tools used in hospitals, clinics, ambulatory surgical centers, as well as research institutes. These tools are used to draw fluids or inject medication from or in a patient’s body. A medical injection needle is injected in the upper layer of the skin, deep enough to facilitate necessary medication to a body area or blood vessel while aiming not to damage any veins, muscles, or tissues. There are several ongoing research activities to develop new syringes and needles that provide more comfort and less pain. Commercially, needles come in various lengths and diameters for different types of injections. Needles are made of hollow stainless steel bodies and consist of a hub – that fits onto the tip of the syringe, a shaft – the long length of the needle, and the bevel – which is the slanted tip of the needle. Needles are classified according to their length and diameter, which may vary from 3 to 5 inches, and their diameter is measured in gauges. The patient may feel less pain and bruising when injected with a higher gauge needle.

The WHO also provides certain statistical data for respective governments and companies, such as emerging case predictions, required doses of vaccinations for each nation, etc. These governments and companies act accordingly and ramp up their efforts to cater to these predicted demands. Several companies across the world have increased their production of injection needles. Also, they have partnered through strategic joint ventures to produce injection needles to meet this increasing global demand. The emerging COVID-19 cases are expected to exponentially surge with the 2nd wave of this virus across several European nations and various developing nations such as India, Brazil, etc. Moreover, respective governments of several nations have initiated mass vaccination drives, and presently more than 1.3 Bn around the world where individuals have had successful COVID-19 vaccinations administered.

To learn more about this report, request for Sample Report

Global Medical Injection Needle Market Revenue Outlook:

The global medical injection needle market was valued at US$ 671.1 Mn in 2020 and is projected to register а САGR of 6.2% by 2031.

Nonetheless, various industry players in the global Medical Injection Needle market are now increasing their focus towards the establishment of successful collaborations, acquisitions, and joint venture activities as a means to enhance their respective customer bases. In doing so, these players are also increasing their supply capabilities to meet customer requirements on a local and global scale. This factor, paired with promising industrialization prospects in developing economies of the Asia-Pacific region, such as China, India, Taiwan, Indonesia, etc., are expected to create massive business opportunities for key players over the forecast period.

Top Exporters of Syringes, with/without Needles Analysis in 2019

• USA - 16.5% of the world exports ~$896 million
• China - 15.2% ~$829 million
• France - 10.5% ~$575 million
• Germany - 9.42% ~$511 million
• Switzerland - 6.46% ~$350 million

According to statistics provided by the major exporters, the largest flows of exports of Syringes, with/without needles» in 2019:

• Exports from China to the USA: 6.04% of the world exports, ~$328 million according to external trade statistics of China
• Exports from France to Germany: 1.92% of the world exports, ~$104 million according to external trade statistics of France
• Exports from Germany to France: 2.45% of the world exports, ~$133 million according to external trade statistics of Germany
• Exports from Mexico to the USA: 2.28% of the world exports, ~$124 million according to external trade statistics of Mexico
• Exports from Switzerland to Germany: 2.28% of the world exports, ~$124 million according to external trade statistics of Switzerland
• Exports from the United Kingdom to France: 1.47% of the world exports, ~$80 million according to external trade statistics of the United Kingdom
• Exports from the USA to Belgium: 1.46% of the world exports, ~$79 million according to external trade statistics of the US
• Exports from the USA to Canada: 1.93% of the world exports, ~$105 million according to external trade statistics of the US
• Exports from the USA to France: 2.72% of the world exports, ~$147 million according to external trade statistics of the US
• Exports from the USA to the Netherlands: 1.39% of the world exports, ~$75 million according to external trade statistics of the US

The increasing prevalence of chronic diseases is boosting the growth of the global medical injection needle market

The increasing incidence and prevalence of chronic diseases such as arthritis, asthma, cancer, diabetes, and cystic fibrosis are continuously increasing the demand for injectable drugs and vaccines. This is a factor that is expected to fuel the projected revenue growth of the global medical injection needles market in the years to come.

• According to a report published by the American Cancer Society in 2020, an estimated 1.8 million new cancer cases have been diagnosed, with 606,520 cancer deaths in the United States alone.
• As per the report published by the Centers for Diseases Control & Prevention on National Diabetes Statistics Report, 2020, approx. 34.2 million individuals, or 10.5% of the US population, suffer from Type 1 or Type 2 diabetes.

Some recent trends expected to have a positive impact on the growth of the market

Several prominent players are increasing their production capacities for injection needles to cater to the increased demand for these products as there is a daily rise in the number of COVID-19 positive cases across the world, coupled with ongoing vaccination drives being undertaken across several nations in North America, South America, Europe, and Asia. This trend is expected to continue and further augment the profit margins of this global market throughout the forecast period.

• In March 2020, the Health and Human Services Department, and the Defense Department, partnered with ApiJect Systems Corporation to increase the syringes and needles production to administer COVID-19 medications.

Competitive Landscape

The medical injection needle landscape appears highly consolidated, with a major chunk of it being dominated by the US players.

• Medtronic plc
• Becton, Dickinson, and Company
• Stryker Corporation
• Medline Industries, Inc.
• Boston Scientific Corporation
• Braun Melsungen AG
• Terumo Corporation
• Cook Group Incorporated
• Hindustan Syringes and Medical Devices Limited
• Hamilton Company
• Other Players

Report Scope

• Forecast Period: 2022-2031
• Actual Year: 2021
• Historical Data Available for: 2015-2020

Key Regions Covered

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Segments Covered

Medical Injection Needle Market, By Product Type

• Hypodermic Needles
• Infusion Needles
• Insulin Needles
• Other Product Type

Medical Injection Needle Market, By Application

• Hospital
• Clinic
• Home Care Setting
• Other Applications

To learn more about this report, request for Sample Report